Medical Prevention of Breast Cancer

被引:11
作者
Stubert, Johannes [1 ]
Dieterich, Max [1 ]
Gerber, Bernd [1 ]
机构
[1] Univ Rostock, Dept Obstet & Gynecol, D-18059 Rostock, Germany
关键词
Breast cancer; Prevention; Tamoxifen; SERMs; Aromatase inhibitors; SURGICAL ADJUVANT BREAST; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; RANDOMIZED-TRIAL; BOWEL PROJECT; CLINICAL-TRIALS; FAMILY-HISTORY; FOLLOW-UP; RISK;
D O I
10.1159/000369573
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer is the most common cancer of women in Western Europe and North America. Effective strategies of medical prevention could reduce the burden of breast cancer mortality. The best evidence for a risk reduction exists for hormonal agents such as tamoxifen and raloxifene (22-72%) or aromatase inhibitors (50-65%). However, the severity of side effects and the lack of evidence for an improved survival compromise the risk/benefit balance. In this review the results of chemoprevention studies, including new treatment approaches, are summarized with critical discussion of their use in clinical practice.
引用
收藏
页码:391 / 396
页数:6
相关论文
共 50 条
  • [31] Endocrine prevention of breast cancer
    Jahan, Nusrat
    Jones, Catherine
    Rahman, Rakhshanda Layeequr
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2021, 530
  • [32] Aromatase inhibitors, tamoxifen, and endometrial cancer in breast cancer survivors
    Chlebowski, Rowan T.
    Schottinger, Joanne E.
    Shi, Jiaxiao
    Chung, Joanie
    Haque, Reina
    CANCER, 2015, 121 (13) : 2147 - 2155
  • [33] Prevention of Breast Cancer (Part II): Risk Reduction Strategies
    Tirona, Maria Tria
    Sehgal, Rajesh
    Ballester, Oscar
    CANCER INVESTIGATION, 2010, 28 (10) : 1070 - 1077
  • [34] Management of women with a hereditary predisposition for breast cancer
    Jatoi, Ismail
    Benson, John R.
    FUTURE ONCOLOGY, 2016, 12 (19) : 2277 - 2288
  • [35] BRCA Mutations and Breast Cancer Prevention
    Kotsopoulos, Joanne
    CANCERS, 2018, 10 (12)
  • [36] Exercise in the prevention and rehabilitation of breast cancer
    Volaklis, Konstantinos A.
    Halle, Martin
    Tokmakidis, Savvas P.
    WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 (11-12) : 297 - 301
  • [37] Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy
    Hines, Stephanie L.
    Sloan, Jeff A.
    Atherton, Pamela J.
    Perez, Edith A.
    Dakhil, Shaker R.
    Johnson, David B.
    Reddy, Pavan S.
    Dalton, Robert J.
    Mattar, Bassam I.
    Loprinzi, Charles L.
    BREAST, 2010, 19 (02) : 92 - 96
  • [38] The prevention of breast cancer
    Cuzick, Jack
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S34 - S35
  • [39] Current status and challenges of breast cancer prevention∼DNA methylation would lead to groundbreaking progress in breast cancer prevention∼
    Tsukioki, Takahiro
    Khan, Seema A.
    Shien, Tadahiko
    GENES AND ENVIRONMENT, 2023, 45 (01)
  • [40] Importance of the physical activity in the prevention of the breast cancer
    Maitre, C.
    BULLETIN DU CANCER, 2009, 96 (05) : 543 - 551